SRF Q1 Results FY27: Net Profit Rises 75.7% to Rs 759 Crore, Board Approves Rs 5 Interim Dividend

July 22, 2026
Posted by: Kunal Singla
Category: News

SRF Q1 FY27: PAT Rs 759 Cr, up 75.7% YoY. Revenue Rs 5,033 Cr, up 31.8%. EBITDA up 49% at Rs 1,237 Cr, margin 24.6%. Board approves Rs 5 interim dividend. Stock down 3.11% at Rs 2,847.50.

SRF Q1 results FY27 were announced on Wednesday, 22 July 2026, with the specialty chemicals, technical textiles and packaging films conglomerate reporting a consolidated net profit of Rs 759 crore for the quarter ended 30 June 2026, up 75.7% from Rs 432 crore in the year ago quarter. Revenue grew 31.8% to Rs 5,033 crore, and the board approved an interim dividend of Rs 5 per share.

Shares of SRF fell 3.11% to Rs 2,847.50 on the NSE on the results day, despite the strong broad based beat across the business.

Click Here – Get Free Investment Predictions

Table of Contents

SRF Q1 Results FY27 Key Takeaways

Here are the most important numbers from the June 2026 quarter at a glance.

Net Profit (PAT): Rs 759 Cr in Q1 FY27 versus Rs 432 Cr in Q1 FY26, up 75.7% year on year.
Revenue: Rs 5,033 Cr in Q1 FY27 versus Rs 3,819 Cr in Q1 FY26, up 31.8% year on year.
EBITDA: Rs 1,237 Cr in Q1 FY27 versus Rs 830 Cr in Q1 FY26, up 49% year on year, with the margin expanding to 24.6% from 21.7%.
The board approved an interim dividend of Rs 5 per share.
Chemicals business revenue grew 26% YoY to Rs 2,315 Cr with EBIT up 27% at Rs 638 Cr.
Technical Textiles business revenue grew 28% YoY to Rs 597 Cr with EBIT of Rs 108 Cr against Rs 38 Cr a year ago.

SRF Q1 Results FY27 Financial Highlights

The table below summarises the consolidated numbers reported in the SRF Q1 results FY27 against the year ago quarter.

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 5,033 Cr	Rs 3,819 Cr	+31.8%
EBITDA	Rs 1,237 Cr	Rs 830 Cr	+49%
Net Profit (PAT)	Rs 759 Cr	Rs 432 Cr	+75.7%

All figures are on a consolidated basis as reported for the quarter ended 30 June 2026, with the EBITDA margin expanding to 24.6% from 21.7% a year ago.

SRF Q1 Results FY27 Performance Analysis

Get Personalised Guidance from a SEBI-Registered Investment Advisor

Growth accelerated down the P&L in the SRF Q1 results FY27, from 31.8% revenue growth to 49% EBITDA growth to 75.7% PAT growth, with the EBITDA margin expanding nearly three percentage points to 24.6%. This is a broad based beat spanning the company’s diversified chemicals, technical textiles and packaging films portfolio.

The Chemicals business, SRF’s largest segment, grew revenue 26% to Rs 2,315 crore with EBIT up 27% to Rs 638 crore in the SRF Q1 results FY27, showing the core specialty and fluorochemicals business continues to scale profitably. The Technical Textiles business was the standout performer on a percentage basis, with EBIT nearly tripling to Rs 108 crore from Rs 38 crore on 28% revenue growth to Rs 597 crore, suggesting a strong recovery in this segment’s profitability.

The interim dividend of Rs 5 per share, approved alongside the results, signals management confidence in the cash generation supporting this quarter’s performance. The 3.11% stock decline despite the strong beat may reflect profit booking after a run into the results or broader market sentiment on the day, since the underlying numbers were comprehensively positive.

SRF Q1 Results FY27: Key Business Factors

1. Chemicals Business Leading Scale

The Chemicals segment, SRF’s largest, grew revenue 26% with EBIT up 27% in the SRF Q1 results FY27, confirming continued strength in the specialty and fluorochemicals franchise.

2. Technical Textiles Profitability Recovery

EBIT in the Technical Textiles business nearly tripled year on year to Rs 108 crore, the standout margin recovery story within the quarter.

3. Broad Based Margin Expansion

The consolidated EBITDA margin expanding to 24.6% from 21.7% in the SRF Q1 results FY27 shows the improvement was not confined to one segment but reflected across the diversified portfolio.

Dividend Details

SRF’s board approved an interim dividend of Rs 5 per share alongside the SRF Q1 results FY27. Investors should track the official NSE and BSE filings for the record date and payment timeline.

SRF Q1 Results FY27 Outlook for the Full Year

After the SRF Q1 results FY27, the key markers for FY27 are whether the Chemicals business can sustain its growth pace, whether the Technical Textiles recovery holds, and how the Performance Films business, not fully detailed in this quarter’s highlights, contributes to the overall mix. Continued margin discipline across segments would support the current growth trajectory.

SRF Stock Performance After the Q1 Results

Download the Univest iOS App or Univest Android App to track SRF live share price and upcoming quarterly results.

SRF share price fell 3.11% to Rs 2,847.50 on the NSE after the SRF Q1 results FY27, despite the broad based beat across the business.

Investors can compare the trend of the counter with the Nifty 500 index to judge how the stock is placed relative to the broader market after the June quarter results.

Key Risks

Investors going through the fine print of these results should also weigh the following risks.

1. Chemicals Segment Cyclicality

The specialty and fluorochemicals business can be cyclical, tied to global agrochemical and pharmaceutical demand cycles, which could affect the segment’s growth trajectory.

2. Sustaining the Technical Textiles Recovery

The near tripling of Technical Textiles EBIT in the SRF Q1 results FY27 sets a high bar, and sustaining this level of profitability will depend on continued demand and pricing in that segment.

3. Currency and Export Market Exposure

As a company with meaningful export exposure across its chemicals and technical textiles businesses, currency movements and global demand trends remain relevant risks.

Conclusion

SRF Q1 results FY27 show net profit up 75.7% at Rs 759 crore with broad based growth across Chemicals and Technical Textiles, alongside a Rs 5 per share interim dividend. Investors should track segment level momentum into FY27 and consult a SEBI-registered advisor before acting on the numbers.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on SRF Q1 Results FY27

When were the SRF Q1 results FY27 announced?

Ans. The SRF Q1 results FY27 were announced on Wednesday, 22 July 2026, for the quarter ended 30 June 2026, on a consolidated basis.

What is the PAT in the SRF Q1 results FY27?

Ans. The consolidated PAT in the SRF Q1 results FY27 stood at Rs 759 crore, up 75.7% from Rs 432 crore in Q1 FY26.

What was the revenue in the SRF Q1 results FY27?

Ans. Revenue in the SRF Q1 results FY27 stood at Rs 5,033 crore, up 31.8% from Rs 3,819 crore in Q1 FY26.

How did the Chemicals business perform in the SRF Q1 results FY27?

Ans. The Chemicals business in the SRF Q1 results FY27 grew revenue 26% year on year to Rs 2,315 crore, with EBIT up 27% to Rs 638 crore.

How did the Technical Textiles business perform in the SRF Q1 results FY27?

Ans. The Technical Textiles business in the SRF Q1 results FY27 grew revenue 28% year on year to Rs 597 crore, with EBIT nearly tripling to Rs 108 crore from Rs 38 crore a year ago.

What dividend was announced with the SRF Q1 results FY27?

Ans. SRF’s board approved an interim dividend of Rs 5 per share alongside the SRF Q1 results FY27.

How did the share price react to the SRF Q1 results FY27?

Ans. SRF share price fell 3.11% to Rs 2,847.50 on the NSE after the SRF Q1 results FY27.

Is the stock a good buy after the SRF Q1 results FY27?

Ans. The SRF Q1 results FY27 show a broad based beat across segments with margin expansion, though chemicals cyclicality and currency exposure are factors to weigh. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.

Q1 Results FY27

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.